{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:39:28Z","timestamp":1790818768659,"version":"4.1.0"},"reference-count":160,"publisher":"Bentham Science Publishers Ltd.","issue":"36","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,11,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Gonadotropin-Releasing Hormone (GnRH) is a key element in sexual maturation and regulation of the reproductive cycle in the human organism. GnRH interacts with the pituitary cells through the activation of the Gonadotropin Releasing Hormone Receptors (GnRHR). Any impairments\/dysfunctions of the GnRH-GnRHR complex lead to the development of various cancer types and disorders. Furthermore, the identification of GnRHR as a potential drug target has led to the development of agonist and antagonist molecules implemented in various treatment protocols. The development of these drugs was based on the information derived from the functional studies of GnRH and GnRHR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This review aims at shedding light on the versatile function of GnRH and GnRH receptor and offers an apprehensive summary regarding the development of different agonists, antagonists and non-peptide GnRH analogues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The information derived from these studies can enhance our understanding of the GnRH-GnRHR versatile nature and offer valuable insight into the design of new more potent molecules.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867326666190712165444","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T08:45:13Z","timestamp":1563266713000},"page":"6136-6158","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Gonadotropin-Releasing Hormone and GnRH Receptor: Structure, Function and Drug Development"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1534-2762","authenticated-orcid":true,"given":"Haralambos","family":"Tzoupis","sequence":"first","affiliation":[{"name":"Department of Chemistry, University of Patras, Rion GR-26504, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0022-3725","authenticated-orcid":true,"given":"Agathi","family":"Nteli","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Patras, Rion GR-26504, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9165-563X","authenticated-orcid":true,"given":"Maria-Eleni","family":"Androutsou","sequence":"additional","affiliation":[{"name":"Vianex S.A., Tatoiou Str., 18th km Athens-Lamia National Road, Nea Erythrea 14671, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1310-0591","authenticated-orcid":true,"given":"Theodore","family":"Tselios","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Patras, Rion GR-26504, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.173.4001.1036","volume":"173","author":"Schally A.V.","year":"1971","unstructured":"Schally A.V.; Arimura A.; Kastin A.J.; Matsuo H.; Baba Y.; Redding T.W.; Nair R.M.; Debeljuk L.; White W.F.; Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science 1971,173(4001),1036-1038","journal-title":"Science"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1210\/er.18.1.46","volume":"18","author":"Kaiser U.B.","year":"1997","unstructured":"Kaiser U.B.; Conn P.M.; Chin W.W.; Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocr Rev 1997,18(1),46-70","journal-title":"Endocr Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1210\/jc.2003-031808","volume":"89","author":"Meysing A.U.","year":"2004","unstructured":"Meysing A.U.; Kanasaki H.; Bedecarrats G.Y.; Acierno J.S.; Conn P.M.; Martin K.A.; Seminara S.B.; Hall J.E.; Crowley W.F.; Kaiser U.B.; GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone. J Clin Endocrinol Metab 2004,89(7),3189-3198","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0006-291X(71)90623-1","volume":"44","author":"Baba Y.","year":"1971","unstructured":"Baba Y.; Matsuo H.; Schally A.V.; Structure of the porcine LH- and FSH-releasing hormone. II. Confirmation of the proposed structure by conventional sequential analyses. Biochem Biophys Res Commun 1971,44(2),459-463","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1095\/biolreprod.105.049049","volume":"74","author":"Ferris H.A.","year":"2006","unstructured":"Ferris H.A.; Shupnik M.A.; Mechanisms for pulsatile regulation of the gonadotropin subunit genes by GNRH1. Biol Reprod 2006,74(6),993-998","journal-title":"Biol Reprod"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1210\/en.2016-1351","volume":"157","author":"Czieselsky K.","year":"2016","unstructured":"Czieselsky K.; Prescott M.; Porteous R.; Campos P.; Clarkson J.; Steyn F.J.; Campbell R.E.; Herbison A.E.; Pulse and surge profiles of luteinizing hormone secretion in the mouse. Endocrinology 2016,157(12),4794-4802","journal-title":"Endocrinology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/humupd\/dmv059","volume":"22","author":"Maggi R.","year":"2016","unstructured":"Maggi R.; Cariboni A.M.; Marelli M.M.; Moretti R.M.; Andr\u00e8 V.; Marzagalli M.; Limonta P.; GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. Hum Reprod Update 2016,22(3),358-381","journal-title":"Hum Reprod Update"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1677\/JOE-08-0544","volume":"202","author":"Joseph N.T.","year":"2009","unstructured":"Joseph N.T.; Morgan K.; Sellar R.; McBride D.; Millar R.P.; Dunn I.C.; The chicken type III GnRH receptor homologue is predominantly expressed in the pituitary and exhibits similar ligand selectivity to the type I receptor. J Endocrinol 2009,202(1),179-190","journal-title":"J Endocrinol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/gcen.1998.7156","volume":"112","author":"Troskie B.","year":"1998","unstructured":"Troskie B.; Illing N.; Rumbak E.; Sun Y.M.; Hapgood J.; Sealfon S.; Conklin D.; Millar R.; Identification of three putative GnRH receptor subtypes in vertebrates. Gen Comp Endocrinol 1998,112(3),296-302","journal-title":"Gen Comp Endocrinol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jne.12491","volume":"29","author":"True C.","year":"2017","unstructured":"True C.; Takahashi D.; Kirigiti M.; Lindsley S.R.; Moctezuma C.; Arik A.; Smith M.S.; Kievit P.; Grove K.L.; Arcuate nucleus neuropeptide coexpression and connections to gonadotrophin-releasing hormone neurones in the female rhesus macaque. J Neuroendocrinol 2017,29(6),29","journal-title":"J Neuroendocrinol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"15060","DOI":"10.1523\/JNEUROSCI.2200-14.2014","volume":"34","author":"Glanowska K.M.","year":"2014","unstructured":"Glanowska K.M.; Burger L.L.; Moenter S.M.; Development of gonadotropin-releasing hormone secretion and pituitary response. J Neurosci 2014,34(45),15060-15069","journal-title":"J Neurosci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11248-017-0023-4","volume":"26","author":"Desaulniers A.T.","year":"2017","unstructured":"Desaulniers A.T.; Cederberg R.A.; Mills G.A.; Lents C.A.; White B.R.; Production of a gonadotropin-releasing hormone 2 receptor knockdown (GNRHR2 KD) swine line. Transgenic Res 2017,26(4),567-575","journal-title":"Transgenic Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/mrd.22830","volume":"84","author":"Lents C.A.","year":"2017","unstructured":"Lents C.A.; Thorson J.F.; Desaulniers A.T.; White B.R.; RFamide-related peptide 3 and gonadotropin-releasing hormone-II are autocrine-paracrine regulators of testicular function in the boar. Mol Reprod Dev 2017,84(9),994-1003","journal-title":"Mol Reprod Dev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ajpath.2014.12.004","volume":"185","author":"Ray D.","year":"2015","unstructured":"Ray D.; Han Y.; Franchitto A.; DeMorrow S.; Meng F.; Venter J.; McMillin M.; Kennedy L.; Francis H.; Onori P.; Mancinelli R.; Gaudio E.; Alpini G.; Glaser S.S.; Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine\/autocrine mechanisms. Am J Pathol 2015,185(4),1061-1072","journal-title":"Am J Pathol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1210\/en.2010-1208","volume":"152","author":"Wen S.","year":"2011","unstructured":"Wen S.; G\u00f6tze I.N.; Mai O.; Schauer C.; Leinders-Zufall T.; Boehm U.; Genetic identification of GnRH receptor neurons: a new model for studying neural circuits underlying reproductive physiology in the mouse brain. Endocrinology 2011,152(4),1515-1526","journal-title":"Endocrinology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/icb\/icn018","volume":"48","author":"Schneider J.S.","year":"2008","unstructured":"Schneider J.S.; Rissman E.F.; Gonadotropin-releasing hormone II: a multi-purpose neuropeptide. Integr Comp Biol 2008,48(5),588-595","journal-title":"Integr Comp Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1677\/joe.1.06423","volume":"188","author":"Mohamed J.S.","year":"2006","unstructured":"Mohamed J.S.; Khan I.A.; Molecular cloning and differential expression of three GnRH mRNAs in discrete brain areas and lymphocytes in red drum. J Endocrinol 2006,188(3),407-416","journal-title":"J Endocrinol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11373-005-7457-z","volume":"12","author":"Kuo M.W.","year":"2005","unstructured":"Kuo M.W.; Lou S.W.; Postlethwait J.; Chung B.C.; Chromosomal organization, evolutionary relationship, and expression of zebrafish GnRH family members. J Biomed Sci 2005,12(4),629-639","journal-title":"J Biomed Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ygcen.2004.09.015","volume":"139","author":"Morgan K.","year":"2004","unstructured":"Morgan K.; Millar R.P.; Evolution of GnRH ligand precursors and GnRH receptors in protochordate and vertebrate species. Gen Comp Endocrinol 2004,139(3),191-197","journal-title":"Gen Comp Endocrinol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1210\/me.2006-0537","volume":"22","author":"L\u00f3pez de Maturana R.","year":"2008","unstructured":"L\u00f3pez de Maturana R.; Pawson A.J.; Lu Z.L.; Davidson L.; Maudsley S.; Morgan K.; Langdon S.P.; Millar R.P.; Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling. Mol Endocrinol 2008,22(7),1711-1722","journal-title":"Mol Endocrinol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1530\/eje.0.1510141","volume":"151","author":"Gr\u00fcndker C.","year":"2004","unstructured":"Gr\u00fcndker C.; Schlotawa L.; Viereck V.; Eicke N.; Horst A.; Kairies B.; Emons G.; Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor. Eur J Endocrinol 2004,151(1),141-149","journal-title":"Eur J Endocrinol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1073\/pnas.96.5.2526","volume":"96","author":"Illing N.","year":"1999","unstructured":"Illing N.; Troskie B.E.; Nahorniak C.S.; Hapgood J.P.; Peter R.E.; Millar R.P.; Two gonadotropin-releasing hormone receptor subtypes with distinct ligand selectivity and differential distribution in brain and pituitary in the goldfish (Carassius auratus). Proc Natl Acad Sci USA 1999,96(5),2526-2531","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.ejogrb.2004.01.033","volume":"115","author":"Coccia M.E.","year":"2004","unstructured":"Coccia M.E.; Comparetto C.; Bracco G.L.; Scarselli G.; GnRH antagonists. Eur J Obstet Gynecol Reprod Biol 2004,115(Suppl. 1),S44-S56","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijpharm.2015.08.095","volume":"495","author":"Varasteh Moradi S.","year":"2015","unstructured":"Varasteh Moradi S.; Varamini P.; Steyn F.; Toth I.; In vivo pharmacological evaluation of a lactose-conjugated luteinizing hormone releasing hormone analogue. Int J Pharm 2015,495(1),106-111","journal-title":"Int J Pharm"},{"key":"ref=25","first-page":"146","volume":"232","author":"Baldwin E.L.","year":"2007","unstructured":"Baldwin E.L.; Wegorzewska I.N.; Flora M.; Wu T.J.; Regulation of type II luteinizing hormone-releasing hormone (LHRH-II) gene expression by the processed peptide of LHRH-I, LHRH-(1-5) in endometrial cells. Exp Biol Med (Maywood) 2007,232(1),146-155","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"33.e1","DOI":"10.1016\/j.ajog.2006.07.054]","volume":"196","author":"Walters K.","year":"2007","unstructured":"Walters K.; Chin Y.P.; Wu T.J.; A processed metabolite of luteinizing hormone-releasing hormone has proliferative effects in endometrial cells. Am J Obstet Gynecol 2007,196(1),33.e1-e5","journal-title":"Am J Obstet Gynecol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.theriogenology.2016.09.032","volume":"88","author":"Hannan M.A.","year":"2017","unstructured":"Hannan M.A.; Kawate N.; Fukami Y.; Weerakoon W.W.; B\u00fcllesbach E.E.; Inaba T.; Tamada H.; Effects of long-acting GnRH antagonist, degarelix acetate, on plasma insulin-like peptide 3, testosterone and luteinizing hormone concentrations, and scrotal circumference in male goats. Theriogenology 2017,88,228-235","journal-title":"Theriogenology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5301\/uro.5000194","volume":"83","author":"Salciccia S.","year":"2016","unstructured":"Salciccia S.; Gentilucci A.; Cattarino S.; Sciarra A.; GNRH-agonist or antagonist in the treatment of prostate cancer: a comparision based on oncological results. Urologia 2016,83(4),173-178","journal-title":"Urologia"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"17921","DOI":"10.1074\/jbc.M610413200","volume":"282","author":"Lu Z.L.","year":"2007","unstructured":"Lu Z.L.; Coetsee M.; White C.D.; Millar R.P.; Structural determinants for ligand-receptor conformational selection in a peptide G protein-coupled receptor. J Biol Chem 2007,282(24),17921-17929","journal-title":"J Biol Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1210\/en.2004-0560","volume":"146","author":"Wu T.J.","year":"2005","unstructured":"Wu T.J.; Mani S.K.; Glucksman M.J.; Roberts J.L.; Stimulation of luteinizing hormone-releasing hormone (LHRH) gene expression in GT1-7 cells by its metabolite, LHRH-(1-5). Endocrinology 2005,146(1),280-286","journal-title":"Endocrinology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1208\/s12248-015-9769-x","volume":"17","author":"Moradi S.V.","year":"2015","unstructured":"Moradi S.V.; Varamini P.; Toth I.; Evaluation of the biological properties and the enzymatic stability of glycosylated luteinizing hormone-releasing hormone analogs. AAPS J 2015,17(5),1135-1143","journal-title":"AAPS J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1046\/j.1365-2826.1997.00637.x","volume":"9","author":"Wu T.J.","year":"1997","unstructured":"Wu T.J.; Pierotti A.R.; Jakubowski M.; Sheward W.J.; Glucksman M.J.; Smith A.I.; King J.C.; Fink G.; Roberts J.L.; Endopeptidase EC 3.4.24.15 presence in the rat median eminence and hypophysial portal blood and its modulation of the luteinizing hormone surge. J Neuroendocrinol 1997,9(11),813-822","journal-title":"J Neuroendocrinol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1210\/en.2005-0652","volume":"146","author":"Tena-Sempere M.","year":"2005","unstructured":"Tena-Sempere M.; Hypothalamic KiSS-1: the missing link in gonadotropin feedback control? Endocrinology 2005,146(9),3683-3685","journal-title":"Endocrinology"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.fertnstert.2014.05.044","volume":"102","author":"Beneduzzi D.","year":"2014","unstructured":"Beneduzzi D.; Trarbach E.B.; Min L.; Jorge A.A.; Garmes H.M.; Renk A.C.; Fichna M.; Fichna P.; Arantes K.A.; Costa E.M.; Zhang A.; Adeola O.; Wen J.; Carroll R.S.; Mendonca B.B.; Kaiser U.B.; Latronico A.C.; Silveira L.F.; Role of gonadotropin-releasing hormone receptor mutations in patients with a wide spectrum of pubertal delay. Fertil Steril 2014,102(3),838-846.e2","journal-title":"Fertil Steril"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1128\/MCB.00848-09","volume":"30","author":"Ciccone N.A.","year":"2010","unstructured":"Ciccone N.A.; Xu S.; Lacza C.T.; Carroll R.S.; Kaiser U.B.; Frequency-dependent regulation of follicle-stimulating hormone beta by pulsatile gonadotropin-releasing hormone is mediated by functional antagonism of bZIP transcription factors. Mol Cell Biol 2010,30(4),1028-1040","journal-title":"Mol Cell Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0022-5193(02)93092-4","volume":"218","author":"Krakauer D.C.","year":"2002","unstructured":"Krakauer D.C.; Page K.M.; Sealfon S.; Module dynamics of the GnRH signal transduction network. J Theor Biol 2002,218(4),457-470","journal-title":"J Theor Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1210\/me.2009-0343","volume":"24","author":"Finch A.R.","year":"2010","unstructured":"Finch A.R.; Caunt C.J.; Armstrong S.P.; McArdle C.A.; Plasma membrane expression of gonadotropin-releasing hormone receptors: regulation by peptide and nonpeptide antagonists. Mol Endocrinol 2010,24(2),423-435","journal-title":"Mol Endocrinol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2008.03.047","volume":"587","author":"Karakoula A.","year":"2008","unstructured":"Karakoula A.; Tovey S.C.; Brighton P.J.; Willars G.B.; Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q\/11. Eur J Pharmacol 2008,587(1-3),16-24","journal-title":"Eur J Pharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"47195","DOI":"10.1074\/jbc.M108716200","volume":"276","author":"Wurmbach E.","year":"2001","unstructured":"Wurmbach E.; Yuen T.; Ebersole B.J.; Sealfon S.C.; Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem 2001,276(50),47195-47201","journal-title":"J Biol Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1074\/jbc.M206607200","volume":"278","author":"Wojcikiewicz R.J.","year":"2003","unstructured":"Wojcikiewicz R.J.; Xu Q.; Webster J.M.; Alzayady K.; Gao C.; Ubiquitination and proteasomal degradation of endogenous and exogenous inositol 1,4,5-trisphosphate receptors in alpha T3-1 anterior pituitary cells. J Biol Chem 2003,278(2),940-947","journal-title":"J Biol Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1677\/JOE-10-0109","volume":"207","author":"Zerani M.","year":"2010","unstructured":"Zerani M.; Parillo F.; Brecchia G.; Guelfi G.; Dall\u2019Aglio C.; Lilli L.; Maranesi M.; Gobbetti A.; Boiti C.; Expression of type I GNRH receptor and in vivo and in vitro GNRH-I effects in corpora lutea of pseudopregnant rabbits. J Endocrinol 2010,207(3),289-300","journal-title":"J Endocrinol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/mrd.20898","volume":"75","author":"Chakrabarti N.","year":"2008","unstructured":"Chakrabarti N.; Subbarao T.; Sengupta A.; Xu F.; Stouffer R.L.; Sridaran R.; Expression of mRNA and proteins for GnRH I and II and their receptors in primate corpus luteum during menstrual cycle. Mol Reprod Dev 2008,75(10),1567-1577","journal-title":"Mol Reprod Dev"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1210\/en.2012-1746","volume":"154","author":"Larco D.O.","year":"2013","unstructured":"Larco D.O.; Cho-Clark M.; Mani S.K.; Wu T.J.; The metabolite GnRH-(1-5) inhibits the migration of immortalized GnRH neurons. Endocrinology 2013,154(2),783-795","journal-title":"Endocrinology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.mce.2015.08.010","volume":"415","author":"Cho-Clark M.","year":"2015","unstructured":"Cho-Clark M.; Larco D.O.; Zahn B.R.; Mani S.K.; Wu T.J.; GnRH-(1-5) activates matrix metallopeptidase-9 to release epidermal growth factor and promote cellular invasion. Mol Cell Endocrinol 2015,415,114-125","journal-title":"Mol Cell Endocrinol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fendo.2013.00083","volume":"4","author":"Larco D.O.","year":"2013","unstructured":"Larco D.O.; Semsarzadeh N.N.; Cho-Clark M.; Mani S.K.; Wu T.J.; The novel actions of the metabolite GnRH-(1-5) are mediated by a G protein-coupled receptor. Front Endocrinol (Lausanne) 2013,4,83","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12020-014-0492-7","volume":"49","author":"Larco D.O.","year":"2015","unstructured":"Larco D.O.; Williams M.; Schmidt L.; Sabel N.; Lange J.; Woller M.J.; Wu T.J.; Autoshortloop feedback regulation of pulsatile gonadotropin-releasing hormone (GnRH) secretion by its metabolite, GnRH-(1-5). Endocrine 2015,49(2),470-478","journal-title":"Endocrine"},{"key":"ref=47","first-page":"1163","volume":"6","author":"Tsutsumi M.","year":"1992","unstructured":"Tsutsumi M.; Zhou W.; Millar R.P.; Mellon P.L.; Roberts J.L.; Flanagan C.A.; Dong K.; Gillo B.; Sealfon S.C.; Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor. Mol Endocrinol 1992,6(7),1163-1169","journal-title":"Mol Endocrinol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1006\/bbrc.1993.1335","volume":"191","author":"Perrin M.H.","year":"1993","unstructured":"Perrin M.H.; Bilezikjian L.M.; Hoeger C.; Donaldson C.J.; Rivier J.; Haas Y.; Vale W.W.; Molecular and functional characterization of GnRH receptors cloned from rat pituitary and a mouse pituitary tumor cell line. Biochem Biophys Res Commun 1993,191(3),1139-1144","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/0303-7207(93)90278-R","volume":"91","author":"Chi L.","year":"1993","unstructured":"Chi L.; Zhou W.; Prikhozhan A.; Flanagan C.; Davidson J.S.; Golembo M.; Illing N.; Millar R.P.; Sealfon S.C.; Cloning and characterization of the human GnRH receptor. Mol Cell Endocrinol 1993,91(1-2),R1-R6","journal-title":"Mol Cell Endocrinol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1006\/bbrc.1993.2312","volume":"196","author":"Illing N.","year":"1993","unstructured":"Illing N.; Jacobs G.F.; Becker I.I.; Flanagan C.A.; Davidson J.S.; Eales A.; Zhou W.; Sealfon S.C.; Millar R.P.; Comparative sequence analysis and functional characterization of the cloned sheep gonadotropin-releasing hormone receptor reveal differences in primary structure and ligand specificity among mammalian receptors. Biochem Biophys Res Commun 1993,196(2),745-751","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.2527\/1994.7271911x","volume":"72","author":"Weesner G.D.","year":"1994","unstructured":"Weesner G.D.; Matteri R.L.; Rapid communication: nucleotide sequence of luteinizing hormone-releasing hormone (LHRH) receptor cDNA in the pig pituitary. J Anim Sci 1994,72(7),1911","journal-title":"J Anim Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1432-1033.1997.0134a.x","volume":"243","author":"Tensen C.","year":"1997","unstructured":"Tensen C.; Okuzawa K.; Blomenr\u00f6hr M.; Rebers F.; Leurs R.; Bogerd J.; Schulz R.; Goos H.; Distinct efficacies for two endogenous ligands on a single cognate gonadoliberin receptor. Eur J Biochem 1997,243(1-2),134-140","journal-title":"Eur J Biochem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1073\/pnas.98.1.361","volume":"98","author":"Wang L.","year":"2001","unstructured":"Wang L.; Bogerd J.; Choi H.S.; Seong J.Y.; Soh J.M.; Chun S.Y.; Blomenr\u00f6hr M.; Troskie B.E.; Millar R.P.; Yu W.H.; McCann S.M.; Kwon H.B.; Three distinct types of GnRH receptor characterized in the bullfrog. Proc Natl Acad Sci USA 2001,98(1),361-366","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1074\/jbc.M009020200","volume":"276","author":"Sun Y.M.","year":"2001","unstructured":"Sun Y.M.; Flanagan C.A.; Illing N.; Ott T.R.; Sellar R.; Fromme B.J.; Hapgood J.; Sharp P.; Sealfon S.C.; Millar R.P.; A chicken gonadotropin-releasing hormone receptor that confers agonist activity to mammalian antagonists. Identification of D-Lys(6) in the ligand and extracellular loop two of the receptor as determinants. J Biol Chem 2001,276(11),7754-7761","journal-title":"J Biol Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1210\/er.2003-0002","volume":"25","author":"Millar R.P.","year":"2004","unstructured":"Millar R.P.; Lu Z.L.; Pawson A.J.; Flanagan C.A.; Morgan K.; Maudsley S.R.; Gonadotropin-releasing hormone receptors. Endocr Rev 2004,25(2),235-275","journal-title":"Endocr Rev"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087901","volume":"9","author":"Sefideh F.A.","year":"2014","unstructured":"Sefideh F.A.; Moon M.J.; Yun S.; Hong S.I.; Hwang J.I.; Seong J.Y.; Local duplication of gonadotropin-releasing hormone (GnRH) receptor before two rounds of whole genome duplication and origin of the mammalian GnRH receptor. PLoS One 2014,9(2)","journal-title":"PLoS One"},{"key":"ref=57","first-page":"1","volume":"53","author":"Ferguson S.S.","year":"2001","unstructured":"Ferguson S.S.; Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001,53(1),1-24","journal-title":"Pharmacol Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"D356","DOI":"10.1093\/nar\/gkv1178","volume":"44","author":"Isberg V.","year":"2016","unstructured":"Isberg V.; Mordalski S.; Munk C.; Rataj K.; Harps\u00f8e K.; Hauser A.S.; Vroling B.; Bojarski A.J.; Vriend G.; Gloriam D.E.; GPCRdb: an information system for G protein-coupled receptors. Nucleic Acids Res 2016,44(D1),D356-D364","journal-title":"Nucleic Acids Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.tem.2004.08.005","volume":"15","author":"Neill J.D.","year":"2004","unstructured":"Neill J.D.; Musgrove L.C.; Duck L.W.; Newly recognized GnRH receptors: function and relative role. Trends Endocrinol Metab 2004,15(8),383-392","journal-title":"Trends Endocrinol Metab"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1043-2760(02)00016-4","volume":"14","author":"Millar R.P.","year":"2003","unstructured":"Millar R.P.; GnRH II and type II GnRH receptors. Trends Endocrinol Metab 2003,14(1),35-43","journal-title":"Trends Endocrinol Metab"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1210\/en.2002-220622","volume":"144","author":"Morgan K.","year":"2003","unstructured":"Morgan K.; Conklin D.; Pawson A.J.; Sellar R.; Ott T.R.; Millar R.P.; A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. Endocrinology 2003,144(2),423-436","journal-title":"Endocrinology"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3892\/ijo.2014.2730","volume":"46","author":"Montagnani Marelli M.","year":"2015","unstructured":"Montagnani Marelli M.; Manea M.; Moretti R.M.; Marzagalli M.; Limonta P.; Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor. Int J Oncol 2015,46(1),243-253","journal-title":"Int J Oncol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1095\/biolreprod.114.127324","volume":"92","author":"Wu H.M.","year":"2015","unstructured":"Wu H.M.; Huang H.Y.; Lee C.L.; Soong Y.K.; Leung P.C.; Wang H.S.; Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the motility of human decidual endometrial stromal cells: possible effect on embryo implantation and pregnancy. Biol Reprod 2015,92(4),98","journal-title":"Biol Reprod"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"34617","DOI":"10.1074\/jbc.M111.240341","volume":"286","author":"Forfar R.","year":"2011","unstructured":"Forfar R.; Lu Z.L.; Role of the transmembrane domain 4\/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection. J Biol Chem 2011,286(40),34617-34626","journal-title":"J Biol Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1210\/en.2005-0133","volume":"146","author":"Pawson A.J.","year":"2005","unstructured":"Pawson A.J.; Maudsley S.; Morgan K.; Davidson L.; Naor Z.; Millar R.P.; Inhibition of human type I gonadotropin-releasing hormone receptor (GnRHR) function by expression of a human type II GnRHR gene fragment. Endocrinology 2005,146(6),2639-2649","journal-title":"Endocrinology"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.289.5480.739","volume":"289","author":"Palczewski K.","year":"2000","unstructured":"Palczewski K.; Kumasaka T.; Hori T.; Behnke C.A.; Motoshima H.; Fox B.A.; Le Trong I.; Teller D.C.; Okada T.; Stenkamp R.E.; Yamamoto M.; Miyano M.; Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000,289(5480),739-745","journal-title":"Science"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"Berman H.M.","year":"2000","unstructured":"Berman H.M.; Westbrook J.; Feng Z.; Gilliland G.; Bhat T.N.; Weissig H.; Shindyalov I.N.; Bourne P.E.; The protein data bank. Nucleic Acids Res 2000,28(1),235-242","journal-title":"Nucleic Acids Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","volume":"36","author":"Isberg V.","year":"2015","unstructured":"Isberg V.; de Graaf C.; Bortolato A.; Cherezov V.; Katritch V.; Marshall F.H.; Mordalski S.; Pin J.P.; Stevens R.C.; Vriend G.; Gloriam D.E.; Generic GPCR residue numbers - aligning topology maps while minding the gaps. Trends Pharmacol Sci 2015,36(1),22-31","journal-title":"Trends Pharmacol Sci"},{"key":"ref=69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004805","volume":"12","author":"Cvicek V.","year":"2016","unstructured":"Cvicek V.; Goddard W.A.; Abrol R.; Structure-based sequence alignment of the transmembrane domains of all human gpcrs: phylogenetic, structural and functional implications. PLOS Comput Biol 2016,12(3)","journal-title":"PLOS Comput Biol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature18324","volume":"535","author":"DeVree B.T.","year":"2016","unstructured":"DeVree B.T.; Mahoney J.P.; V\u00e9lez-Ruiz G.A.; Rasmussen S.G.; Kuszak A.J.; Edwald E.; Fung J.J.; Manglik A.; Masureel M.; Du Y.; Matt R.A.; Pardon E.; Steyaert J.; Kobilka B.K.; Sunahara R.K.; Allosteric coupling from G protein to the agonist-binding pocket in GPCRs. Nature 2016,535(7610),182-186","journal-title":"Nature"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jmgm.2019.03.009","volume":"89","author":"Tzoupis H.","year":"2019","unstructured":"Tzoupis H.; Nteli A.; Platts J.; Mantzourani E.; Tselios T.; Refinement of the gonadotropin releasing hormone receptor I homology model by applying molecular dynamics. J Mol Graph Model 2019,89,147-155","journal-title":"J Mol Graph Model"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1210\/endo.137.2.8593815","volume":"137","author":"Awara W.M.","year":"1996","unstructured":"Awara W.M.; Guo C.H.; Conn P.M.; Effects of Asn318 and Asp87Asn318 mutations on signal transduction by the gonadotropin-releasing hormone receptor and receptor regulation. Endocrinology 1996,137(2),655-662","journal-title":"Endocrinology"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"28880","DOI":"10.1074\/jbc.274.41.28880","volume":"274","author":"Flanagan C.A.","year":"1999","unstructured":"Flanagan C.A.; Zhou W.; Chi L.; Yuen T.; Rodic V.; Robertson D.; Johnson M.; Holland P.; Millar R.P.; Weinstein H.; Mitchell R.; Sealfon S.C.; The functional microdomain in transmembrane helices 2 and 7 regulates expression, activation, and coupling pathways of the gonadotropin-releasing hormone receptor. J Biol Chem 1999,274(41),28880-28886","journal-title":"J Biol Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1073\/pnas.082666399","volume":"99","author":"Okada T.","year":"2002","unstructured":"Okada T.; Fujiyoshi Y.; Silow M.; Navarro J.; Landau E.M.; Shichida Y.; Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc Natl Acad Sci USA 2002,99(9),5982-5987","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jmb.2011.08.044","volume":"413","author":"Murakami M.","year":"2011","unstructured":"Murakami M.; Kouyama T.; Crystallographic analysis of the primary photochemical reaction of squid rhodopsin. J Mol Biol 2011,413(3),615-627","journal-title":"J Mol Biol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1042\/bj3610515","volume":"361","author":"Blomenr\u00f6hr M.","year":"2002","unstructured":"Blomenr\u00f6hr M.; ter Laak T.; K\u00fchne R.; Beyermann M.; Hund E.; Bogerd J.; Leurs R.; Chimaeric gonadotropin-releasing hormone (GnRH) peptides with improved affinity for the catfish (Clarias gariepinus) GnRH receptor. Biochem J 2002,361(Pt 3),515-523","journal-title":"Biochem J"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"10305","DOI":"10.1021\/bi800911z","volume":"47","author":"Coetsee M.","year":"2008","unstructured":"Coetsee M.; Millar R.P.; Flanagan C.A.; Lu Z.L.; Identification of Tyr(290(6.58)) of the human gonadotropin-releasing hormone (GnRH) receptor as a contact residue for both GnRH I and GnRH II: importance for high-affinity binding and receptor activation. Biochemistry 2008,47(39),10305-10313","journal-title":"Biochemistry"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1124\/mol.107.040816","volume":"73","author":"Stewart A.J.","year":"2008","unstructured":"Stewart A.J.; Sellar R.; Wilson D.J.; Millar R.P.; Lu Z.L.; Identification of a novel ligand binding residue Arg38(1.35) in the human gonadotropin-releasing hormone receptor. Mol Pharmacol 2008,73(1),75-81","journal-title":"Mol Pharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.bi.63.070194.000533","volume":"63","author":"Strader C.D.","year":"1994","unstructured":"Strader C.D.; Fong T.M.; Tota M.R.; Underwood D.; Dixon R.A.; Structure and function of G protein-coupled receptors. Annu Rev Biochem 1994,63,101-132","journal-title":"Annu Rev Biochem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1210\/jc.86.6.2680","volume":"86","author":"Costa E.M.","year":"2001","unstructured":"Costa E.M.; Bedecarrats G.Y.; Mendonca B.B.; Arnhold I.J.; Kaiser U.B.; Latronico A.C.; Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction. J Clin Endocrinol Metab 2001,86(6),2680-2686","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0303-7207(03)00201-6","volume":"205","author":"B\u00e9d\u00e9carrats G.Y.","year":"2003","unstructured":"B\u00e9d\u00e9carrats G.Y.; Linher K.D.; Janovick J.A.; Beranova M.; Kada F.; Seminara S.B.; Michael Conn P.; Kaiser U.B.; Four naturally occurring mutations in the human GnRH receptor affect ligand binding and receptor function. Mol Cell Endocrinol 2003,205(1-2),51-64","journal-title":"Mol Cell Endocrinol"},{"key":"ref=82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038456","volume":"7","author":"Tello J.A.","year":"2012","unstructured":"Tello J.A.; Newton C.L.; Bouligand J.; Guiochon-Mantel A.; Millar R.P.; Young J.; Congenital hypogonadotropic hypogonadism due to GnRH receptor mutations in three brothers reveal sites affecting conformation and coupling. PLoS One 2012,7(6)","journal-title":"PLoS One"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2018.11.009","volume":"481","author":"Manilall A.","year":"2019","unstructured":"Manilall A.; Stander B.A.; Madziva M.T.; Millar R.P.; Flanagan C.A.; Glu(2.53(90)) of the GnRH receptor is part of the conserved G protein-coupled receptor structure and does not form a salt-bridge with Lys(3.32(121)). Mol Cell Endocrinol 2019,481,53-61","journal-title":"Mol Cell Endocrinol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"8133","DOI":"10.1021\/bi000085g","volume":"39","author":"Flanagan C.A.","year":"2000","unstructured":"Flanagan C.A.; Rodic V.; Konvicka K.; Yuen T.; Chi L.; Rivier J.E.; Millar R.P.; Weinstein H.; Sealfon S.C.; Multiple interactions of the Asp(2.61(98)) side chain of the gonadotropin-releasing hormone receptor contribute differentially to ligand interaction. Biochemistry 2000,39(28),8133-8141","journal-title":"Biochemistry"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1210\/mend.14.7.0483","volume":"14","author":"Hoffmann S.H.","year":"2000","unstructured":"Hoffmann S.H.; ter Laak T.; K\u00fchne R.; Reil\u00e4nder H.; Beckers T.; Residues within transmembrane helices 2 and 5 of the human gonadotropin-releasing hormone receptor contribute to agonist and antagonist binding. Mol Endocrinol 2000,14(7),1099-1115","journal-title":"Mol Endocrinol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0303-7207(94)03449-4","volume":"107","author":"Davidson J.S.","year":"1995","unstructured":"Davidson J.S.; Flanagan C.A.; Zhou W.; Becker I.I.; Elario R.; Emeran W.; Sealfon S.C.; Millar R.P.; Identification of N-glycosylation sites in the gonadotropin-releasing hormone receptor: role in receptor expression but not ligand binding. Mol Cell Endocrinol 1995,107(2),241-245","journal-title":"Mol Cell Endocrinol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/humrep\/dey339]","volume":"34","author":"Maione L.","year":"2018","unstructured":"Maione L.; Fevre A.; Nettore I.C.; Manilall A.; Francou B.; Trabado S.; Bouligand J.; Guiochon-Mantel A.; Delemer B.; Flanagan C.A.; Macchia P.E.; Millar R.P.; Young J.; Similarities and differences in the reproductive phenotypes of women with congenital hypogonadotrophic hypogonadism caused by GNRHR mutations and women with polycystic ovary syndrome. Hum Reprod 2018,34(1),137-147","journal-title":"Hum Reprod"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"K9","DOI":"10.1530\/EJE-16-0968","volume":"176","author":"Caburet S.","year":"2017","unstructured":"Caburet S.; Fruchter R.B.; Legois B.; Fellous M.; Shalev S.; Veitia R.A.; A homozygous mutation of GNRHR in a familial case diagnosed with polycystic ovary syndrome. Eur J Endocrinol 2017,176(5),K9-K14","journal-title":"Eur J Endocrinol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"10445","DOI":"10.1074\/jbc.273.17.10445","volume":"273","author":"Ballesteros J.","year":"1998","unstructured":"Ballesteros J.; Kitanovic S.; Guarnieri F.; Davies P.; Fromme B.J.; Konvicka K.; Chi L.; Millar R.P.; Davidson J.S.; Weinstein H.; Sealfon S.C.; Functional microdomains in G-protein-coupled receptors. The conserved arginine-cage motif in the gonadotropin-releasing hormone receptor. J Biol Chem 1998,273(17),10445-10453","journal-title":"J Biol Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1210\/mend.13.6.0291","volume":"13","author":"Arora K.K.","year":"1999","unstructured":"Arora K.K.; Chung H.O.; Catt K.J.; Influence of a species-specific extracellular amino acid on expression and function of the human gonadotropin-releasing hormone receptor. Mol Endocrinol 1999,13(6),890-896","journal-title":"Mol Endocrinol"},{"key":"ref=91","first-page":"267","volume":"12","author":"de Roux N.","year":"1999","unstructured":"de Roux N.; Young J.; Misrahi M.; Schaison G.; Milgrom E.; Loss of function mutations of the GnRH receptor: a new cause of hypogonadotropic hypogonadism. J Pediatr Endocrinol Metab 1999,12(Suppl. 1),267-275","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"29796","DOI":"10.1074\/jbc.M413520200","volume":"280","author":"Lu Z.L.","year":"2005","unstructured":"Lu Z.L.; Gallagher R.; Sellar R.; Coetsee M.; Millar R.P.; Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations. J Biol Chem 2005,280(33),29796-29803","journal-title":"J Biol Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1021\/jm0506928","volume":"49","author":"Betz S.F.","year":"2006","unstructured":"Betz S.F.; Reinhart G.J.; Lio F.M.; Chen C.; Struthers R.S.; Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor. J Med Chem 2006,49(2),637-647","journal-title":"J Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1021\/bi0113162","volume":"41","author":"H\u00f6velmann S.","year":"2002","unstructured":"H\u00f6velmann S.; Hoffmann S.H.; K\u00fchne R.; ter Laak T.; Reil\u00e4nder H.; Beckers T.; Impact of aromatic residues within transmembrane helix 6 of the human gonadotropin-releasing hormone receptor upon agonist and antagonist binding. Biochemistry 2002,41(4),1129-1136","journal-title":"Biochemistry"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1124\/mol.60.6.1280","volume":"60","author":"Fromme B.J.","year":"2001","unstructured":"Fromme B.J.; Katz A.A.; Roeske R.W.; Millar R.P.; Flanagan C.A.; Role of aspartate7.32(302) of the human gonadotropin-releasing hormone receptor in stabilizing a high-affinity ligand conformation. Mol Pharmacol 2001,60(6),1280-1287","journal-title":"Mol Pharmacol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mce.2004.01.009","volume":"219","author":"Fromme B.J.","year":"2004","unstructured":"Fromme B.J.; Katz A.A.; Millar R.P.; Flanagan C.A.; Pro7.33(303) of the human GnRH receptor regulates selective binding of mammalian GnRH. Mol Cell Endocrinol 2004,219(1-2),47-59","journal-title":"Mol Cell Endocrinol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1530\/EC-17-0104","volume":"6","author":"Gon\u00e7alves C.I.","year":"2017","unstructured":"Gon\u00e7alves C.I.; Arag\u00fc\u00e9s J.M.; Bastos M.; Barros L.; Vicente N.; Carvalho D.; Lemos M.C.; GNRHR biallelic and digenic mutations in patients with normosmic congenital hypogonadotropic hypogonadism. Endocr Connect 2017,6(6),360-366","journal-title":"Endocr Connect"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"15510","DOI":"10.1074\/jbc.271.26.15510","volume":"271","author":"Davidson J.S.","year":"1996","unstructured":"Davidson J.S.; McArdle C.A.; Davies P.; Elario R.; Flanagan C.A.; Millar R.P.; Asn102 of the gonadotropin-releasing hormone receptor is a critical determinant of potency for agonists containing C-terminal glycinamide. J Biol Chem 1996,271(26),15510-15514","journal-title":"J Biol Chem"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature09795","volume":"471","author":"Standfuss J.","year":"2011","unstructured":"Standfuss J.; Edwards P.C.; D\u2019Antona A.; Fransen M.; Xie G.; Oprian D.D.; Schertler G.F.; The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 2011,471(7340),656-660","journal-title":"Nature"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cbic.200600429","volume":"8","author":"Pardo L.","year":"2007","unstructured":"Pardo L.; Deupi X.; D\u00f6lker N.; L\u00f3pez-Rodr\u00edguez M.L.; Campillo M.; The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors. ChemBioChem 2007,8(1),19-24","journal-title":"ChemBioChem"},{"key":"ref=101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174452","volume":"12","author":"Busby E.R.","year":"2017","unstructured":"Busby E.R.; Sherwood N.M.; Gonadotropin-releasing hormone receptor (Gnrhr) gene knock out: normal growth and development of sensory, motor and spatial orientation behavior but altered metabolism in neonatal and prepubertal mice. PLoS One 2017,12(3)","journal-title":"PLoS One"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"15297","DOI":"10.1523\/JNEUROSCI.3061-14.2014","volume":"34","author":"Clarkson J.","year":"2014","unstructured":"Clarkson J.; Busby E.R.; Kirilov M.; Sch\u00fctz G.; Sherwood N.M.; Herbison A.E.; Sexual differentiation of the brain requires perinatal kisspeptin-GnRH neuron signaling. J Neurosci 2014,34(46),15297-15305","journal-title":"J Neurosci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1210\/en.2009-0598","volume":"151","author":"Wu S.","year":"2010","unstructured":"Wu S.; Wilson M.D.; Busby E.R.; Isaac E.R.; Sherwood N.M.; Disruption of the single copy gonadotropin-releasing hormone receptor in mice by gene trap: severe reduction of reproductive organs and functions in developing and adult mice. Endocrinology 2010,151(3),1142-1152","journal-title":"Endocrinology"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1530\/JME-16-0212","volume":"58","author":"Evans M.C.","year":"2017","unstructured":"Evans M.C.; Anderson G.M.; Neuroendocrine integration of nutritional signals on reproduction. J Mol Endocrinol 2017,58(2),R107-R128","journal-title":"J Mol Endocrinol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1210\/en.2011-0096","volume":"152","author":"Louis G.W.","year":"2011","unstructured":"Louis G.W.; Greenwald-Yarnell M.; Phillips R.; Coolen L.M.; Lehman M.N.; Myers M.G.; Molecular mapping of the neural pathways linking leptin to the neuroendocrine reproductive axis. Endocrinology 2011,152(6),2302-2310","journal-title":"Endocrinology"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0006-291X(71)90766-2","volume":"43","author":"Schally A.V.","year":"1971","unstructured":"Schally A.V.; Arimura A.; Baba Y.; Nair R.M.; Matsuo H.; Redding T.W.; Debeljuk L.; Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun 1971,43(2),393-399","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/S0006-291X(71)80019-0","volume":"43","author":"Matsuo H.","year":"1971","unstructured":"Matsuo H.; Baba Y.; Nair R.M.; Arimura A.; Schally A.V.; Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun 1971,43(6),1334-1339","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1210\/edrv-7-1-44","volume":"7","author":"Karten M.J.","year":"1986","unstructured":"Karten M.J.; Rivier J.E.; Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. Endocr Rev 1986,7(1),44-66","journal-title":"Endocr Rev"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1210\/edrv.18.2.0295","volume":"18","author":"Sealfon S.C.","year":"1997","unstructured":"Sealfon S.C.; Weinstein H.; Millar R.P.; Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev 1997,18(2),180-205","journal-title":"Endocr Rev"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1021\/mp0700514","volume":"4","author":"Engel J.B.","year":"2007","unstructured":"Engel J.B.; Schally A.V.; Dietl J.; Rieger L.; H\u00f6nig A.; Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones. Mol Pharm 2007,4(5),652-658","journal-title":"Mol Pharm"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0090-4295(01)01342-5","volume":"58","author":"McLeod D.","year":"2001","unstructured":"McLeod D.; Zinner N.; Tomera K.; Gleason D.; Fotheringham N.; Campion M.; Garnick M.B.; Abarelix Study Group A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer. Urology 2001,58(5),756-761","journal-title":"Urology"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1517\/17425255.2015.1085506","volume":"11","author":"Klotz L.","year":"2015","unstructured":"Klotz L.; Pharmacokinetic and pharmacodynamic profile of degarelix for prostate cancer. Expert Opin Drug Metab Toxicol 2015,11(11),1795-1802","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.2174\/092986706777935041","volume":"13","author":"Gentilucci L.","year":"2006","unstructured":"Gentilucci L.; Tolomelli A.; Squassabia F.; Peptides and peptidomimetics in medicine, surgery and biotechnology. Curr Med Chem 2006,13(20),2449-2466","journal-title":"Curr Med Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5935\/1518-0557.20180090","volume":"23","author":"F\u00e0bregues F.","year":"2019","unstructured":"F\u00e0bregues F.; Solernou R.; Ferreri J.; Guimer\u00e1 M.; Peralta S.; Casals G.; Pe\u00f1arrubia J.; Creus M.; Manau D.; Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders. JBRA Assist Reprod 2019,23(2),130-136","journal-title":"JBRA Assist Reprod"},{"key":"ref=115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208576","volume":"13","author":"El Hachem H.","year":"2018","unstructured":"El Hachem H.; Sonigo C.; Benard J.; Presse M.; Sifer C.; Sermondade N.; Grynberg M.; Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation. PLoS One 2018,13(12)","journal-title":"PLoS One"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.yhbeh.2016.11.007","volume":"89","author":"Burnham V.","year":"2017","unstructured":"Burnham V.; Sundby C.; Laman-Maharg A.; Thornton J.; Luteinizing hormone acts at the hippocampus to dampen spatial memory. Horm Behav 2017,89,55-63","journal-title":"Horm Behav"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jnc.12706","volume":"130","author":"Palm R.","year":"2014","unstructured":"Palm R.; Chang J.; Blair J.; Garcia-Mesa Y.; Lee H.G.; Castellani R.J.; Smith M.A.; Zhu X.; Casadesus G.; Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice. J Neurochem 2014,130(1),115-125","journal-title":"J Neurochem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1200\/JCO.2015.66.3997","volume":"34","author":"Bowen R.L.","year":"2016","unstructured":"Bowen R.L.; Butler T.; Atwood C.S.; Not all androgen deprivation therapies are created equal: leuprolide and the decreased risk of developing Alzheimer\u2019s disease. J Clin Oncol 2016,34(23),2800","journal-title":"J Clin Oncol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/0006-291X(72)90467-6","volume":"49","author":"Fujino M.","year":"1972","unstructured":"Fujino M.; Kobayashi S.; Obayashi M.; Fukuda T.; Shinagawa S.; Synthesis and biological activities of analogs of luteinizing hormone releasing hormone (LH-RH). Biochem Biophys Res Commun 1972,49(3),698-705","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1056\/NEJMoa066494","volume":"357","author":"Raivio T.","year":"2007","unstructured":"Raivio T.; Falardeau J.; Dwyer A.; Quinton R.; Hayes F.J.; Hughes V.A.; Cole L.W.; Pearce S.H.; Lee H.; Boepple P.; Crowley W.F.; Pitteloud N.; Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 2007,357(9),863-873","journal-title":"N Engl J Med"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.fertnstert.2015.01.012","volume":"103","author":"Casper R.F.","year":"2015","unstructured":"Casper R.F.; Introduction: Gonadotropin-releasing hormone agonist triggering of final follicular maturation for in vitro fertilization. Fertil Steril 2015,103(4),865-866","journal-title":"Fertil Steril"},{"key":"ref=122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009154.pub3","volume":"2015","author":"van der Linden M.","year":"2015","unstructured":"van der Linden M.; Buckingham K.; Farquhar C.; Kremer J.A.; Metwally M.; Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2015,2015(7)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13048-019-0483-7","volume":"12","author":"Engmann L.L.","year":"2019","unstructured":"Engmann L.L.; Maslow B.S.; Kaye L.A.; Griffin D.W.; DiLuigi A.J.; Schmidt D.W.; Grow D.R.; Nulsen J.C.; Benadiva C.A.; Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35\u2009h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial. J Ovarian Res 2019,12(1),8","journal-title":"J Ovarian Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/GCO.0000000000000084","volume":"26","author":"Platteeuw L.","year":"2014","unstructured":"Platteeuw L.; D\u2019Hooghe T.; Novel agents for the medical treatment of endometriosis. Curr Opin Obstet Gynecol 2014,26(4),243-252","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1530\/eje.0.1510619","volume":"151","author":"Gr\u00fcndker C.","year":"2004","unstructured":"Gr\u00fcndker C.; G\u00fcnthert A.R.; Hellriegel M.; Emons G.; Gonadotropin-releasing hormone (GnRH) agonist triptorelin inhibits estradiol-induced serum response element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cells. Eur J Endocrinol 2004,151(5),619-628","journal-title":"Eur J Endocrinol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.1158\/0008-5472.CAN-08-4657","volume":"69","author":"Fister S.","year":"2009","unstructured":"Fister S.; G\u00fcnthert A.R.; Aicher B.; Paulini K.W.; Emons G.; Gr\u00fcndker C.; GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax. Cancer Res 2009,69(16),6473-6481","journal-title":"Cancer Res"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"R301","DOI":"10.1530\/ERC-13-0165","volume":"21","author":"Labrie F.","year":"2014","unstructured":"Labrie F.; GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer. Endocr Relat Cancer 2014,21(4),R301-R317","journal-title":"Endocr Relat Cancer"},{"key":"ref=128","first-page":"599","volume":"32","author":"Kittai A.S.","year":"2018","unstructured":"Kittai A.S.; Blank J.; Graff J.N.; Gonadotropin-releasing hormone antagonists in prostate cancer. Oncology (Williston Park) 2018,32(12),599-602, 604-606","journal-title":"Oncology (Williston Park)"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/21681805.2018.1522372]","volume":"52","author":"Crawford E.D.","year":"2018","unstructured":"Crawford E.D.; Tombal B.; Keane T.; Boccardo F.; Miller K.; Shore N.; Moul J.W.; Damber J.E.; Collette L.; Persson B.E.; FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist. Scand J Urol 2018,52(5-6),349-357","journal-title":"Scand J Urol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1517\/14656566.2013.834328","volume":"14","author":"Rick F.G.","year":"2013","unstructured":"Rick F.G.; Block N.L.; Schally A.V.; Agonists of luteinizing hormone-releasing hormone in prostate cancer. Expert Opin Pharmacother 2013,14(16),2237-2247","journal-title":"Expert Opin Pharmacother"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10815-015-0428-z","volume":"32","author":"Cardozo E.R.","year":"2015","unstructured":"Cardozo E.R.; Thomson A.P.; Karmon A.E.; Dickinson K.A.; Wright D.L.; Sabatini M.E.; Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience. J Assist Reprod Genet 2015,32(4),587-596","journal-title":"J Assist Reprod Genet"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/GCO.0b013e328348a3ce","volume":"23","author":"Tan O.","year":"2011","unstructured":"Tan O.; Bukulmez O.; Biochemistry, molecular biology and cell biology of gonadotropin-releasing hormone antagonists. Curr Opin Obstet Gynecol 2011,23(4),238-244","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/bip.21521","volume":"96","author":"Pappa E.V.","year":"2011","unstructured":"Pappa E.V.; Zompra A.A.; Spyranti Z.; Diamantopoulou Z.; Pairas G.; Lamari F.N.; Katsoris P.; Spyroulias G.A.; Cordopatis P.; Enzymatic stability, solution structure and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs. Biopolymers 2011,96(3),260-272","journal-title":"Biopolymers"},{"key":"ref=134","first-page":"642","volume":"46","author":"Shao W.M.","year":"2014","unstructured":"Shao W.M.; Bai W.J.; Chen Y.M.; Liu L.; Wang Y.J.; Micropump infusion of gonadorelin in the treatment of hypogonadotropic hypogonadism in patients with pituitary stalk interruption syndrome: cases analysis and literature review. Beijing Da Xue Xue Bao Yi Xue Ban, 2014,46(4),642-645","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban,"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1177\/106002809002401212","volume":"24","author":"Letassy N.A.","year":"1990","unstructured":"Letassy N.A.; Thompson D.F.; Britton M.L.; Suda R.R.; Nafarelin acetate: a gonadotropin-releasing hormone agonist for the treatment of endometriosis. DICP 1990,24(12),1204-1209","journal-title":"DICP"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1464-410X.2011.10370.x","volume":"109","author":"Shore N.","year":"2012","unstructured":"Shore N.; Cookson M.S.; Gittelman M.C.; Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer. BJU Int 2012,109(2),226-232","journal-title":"BJU Int"},{"key":"ref=137","first-page":"1","volume":"3","author":"Lewis K.A.","year":"2009","unstructured":"Lewis K.A.; Eugster E.A.; Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty. Drug Des Devel Ther 2009,3,1-5","journal-title":"Drug Des Devel Ther"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1515\/JPEM.2000.13.S1.723","volume":"13","author":"Lahlou N.","year":"2000","unstructured":"Lahlou N.; Carel J.C.; Chaussain J.L.; Roger M.; Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrinol Metab 2000,13(Suppl. 1),723-737","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/21681805.1991.12068880","volume":"138","author":"de Voogt H.J.","year":"1991","unstructured":"de Voogt H.J.; Adenauer H.; Widdra W.G.; The use of the LHRH-analogue Buserelin in the treatment of prostatic cancer. A 10-year review on 1522 patients treated in 119 centres on 4 continents. Scand J Urol Nephrol Suppl 1991,138,131-136","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1200\/JCO.2002.05.042","volume":"20","author":"Jonat W.","year":"2002","unstructured":"Jonat W.; Kaufmann M.; Sauerbrei W.; Blamey R.; Cuzick J.; Namer M.; Fogelman I.; de Haes J.C.; de Matteis A.; Stewart A.; Eiermann W.; Szakolczai I.; Palmer M.; Schumacher M.; Geberth M.; Lisboa B.; Zoladex Early Breast Cancer Research Association Study. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: the Zoladex early breast cancer research association study. J Clin Oncol 2002,20(24),4628-4635","journal-title":"J Clin Oncol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.fertnstert.2009.02.062","volume":"94","author":"Lin Y.H.","year":"2010","unstructured":"Lin Y.H.; Wen Y.R.; Chang Y.; Seow K.M.; Hsieh B.C.; Hwang J.L.; Tzeng C.R.; Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study. Fertil Steril 2010,94(1),179-183","journal-title":"Fertil Steril"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.clinthera.2009.11.009","volume":"31","author":"Steinberg M.","year":"2009","unstructured":"Steinberg M.; Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer. Clin Ther 2009,31(Pt 2),2312-2331","journal-title":"Clin Ther"},{"key":"ref=143","first-page":"415","volume":"57","author":"Royster G.D.","year":"2012","unstructured":"Royster G.D.; Retzloff M.G.; Robinson R.D.; King J.A.; Propst A.M.; Effect of length of controlled ovarian hyperstimulation using a gonadotropin-releasing hormone antagonist on in vitro fertilization pregnancy rates. J Reprod Med 2012,57(9-10),415-420","journal-title":"J Reprod Med"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0090-8258(03)00408-6","volume":"90","author":"Verschraegen C.F.","year":"2003","unstructured":"Verschraegen C.F.; Westphalen S.; Hu W.; Loyer E.; Kudelka A.; V\u00f6lker P.; Kavanagh J.; Steger M.; Schulz K.D.; Emons G.; Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer. Gynecol Oncol 2003,90(3),552-559","journal-title":"Gynecol Oncol"},{"key":"ref=145","first-page":"317","volume":"30","author":"Hosseini S.A.","year":"2016","unstructured":"Hosseini S.A.; Rajabi F.; Akbari Sari A.; Ayati M.; Heidari S.; Ghamary F.; Degarelix for the treatment of advanced prostate cancer compared with GnRh-Agonists: a systematic review and meta-analysis. Med J Islam Repub Iran 2016,30,317","journal-title":"Med J Islam Repub Iran"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.urolonc.2014.11.006","volume":"33","author":"Rick F.G.","year":"2015","unstructured":"Rick F.G.; Schally A.V.; Bench-to-bedside development of agonists and antagonists of luteinizing hormone-releasing hormone for treatment of advanced prostate cancer. Urol Oncol 2015,33(6),270-274","journal-title":"Urol Oncol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.eururo.2013.10.032","volume":"65","author":"Albertsen P.C.","year":"2014","unstructured":"Albertsen P.C.; Klotz L.; Tombal B.; Grady J.; Olesen T.K.; Nilsson J.; Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist. Eur Urol 2014,65(3),565-573","journal-title":"Eur Urol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00404-012-2335-1","volume":"286","author":"Engel J.B.","year":"2012","unstructured":"Engel J.B.; Schally A.V.; Buchholz S.; Seitz S.; Emons G.; Ortmann O.; Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH). Arch Gynecol Obstet 2012,286(2),437-442","journal-title":"Arch Gynecol Obstet"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ygyno.2014.03.576","volume":"133","author":"Emons G.","year":"2014","unstructured":"Emons G.; Gorchev G.; Sehouli J.; Wimberger P.; St\u00e4hle A.; Hanker L.; Hilpert F.; Sindermann H.; Gr\u00fcndker C.; Harter P.; Efficacy and safety of AEZS-108 (INN: zoptarelin doxorubicin acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: a multicenter phase II trial of the ago-study group (AGO GYN 5). Gynecol Oncol 2014,133(3),427-432","journal-title":"Gynecol Oncol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10549-004-8806-8","volume":"87","author":"G\u00fcnthert A.R.","year":"2004","unstructured":"G\u00fcnthert A.R.; Gr\u00fcndker C.; Bongertz T.; Nagy A.; Schally A.V.; Emons G.; Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system. Breast Cancer Res Treat 2004,87(3),255-264","journal-title":"Breast Cancer Res Treat"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1021\/jm200216q","volume":"54","author":"Miwa K.","year":"2011","unstructured":"Miwa K.; Hitaka T.; Imada T.; Sasaki S.; Yoshimatsu M.; Kusaka M.; Tanaka A.; Nakata D.; Furuya S.; Endo S.; Hamamura K.; Kitazaki T.; Discovery of 1-4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptor. J Med Chem 2011,54,4998-5012","journal-title":"J Med Chem"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/molecules22122188","volume":"22","author":"Tukun F.L.","year":"2017","unstructured":"Tukun F.L.; Olberg D.E.; Riss P.J.; Haraldsen I.; Kaass A.; Klaveness J.; Recent development of non-peptide GnRH antagonists. Molecules 2017,22(12),22","journal-title":"Molecules"},{"key":"ref=153","first-page":"69","volume":"35","author":"Dmowski W.P.","year":"1990","unstructured":"Dmowski W.P.; Danazol. A synthetic steroid with diverse biologic effects. J Reprod Med 1990,35(1)(Suppl.),69-74","journal-title":"J Reprod Med"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0015-0282(16)60666-0","volume":"51","author":"Fedele L.","year":"1989","unstructured":"Fedele L.; Bianchi S.; Viezzoli T.; Arcaini L.; Candiani G.B.; Gestrinone versus danazol in the treatment of endometriosis. Fertil Steril 1989,51(5),781-785","journal-title":"Fertil Steril"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1021\/jm8006454","volume":"51","author":"Chen C.","year":"2008","unstructured":"Chen C.; Wu D.; Guo Z.; Xie Q.; Reinhart G.J.; Madan A.; Wen J.; Chen T.; Huang C.Q.; Chen M.; Chen Y.; Tucci F.C.; Rowbottom M.; Pontillo J.; Zhu Y.F.; Wade W.; Saunders J.; Bozigian H.; Struthers R.S.; Discovery of sodium R-(+)-4-2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4 -methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylaminobutyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptor. J Med Chem 2008,51,7478-7485","journal-title":"J Med Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1210\/jc.2002-021065","volume":"88","author":"Hara T.","year":"2003","unstructured":"Hara T.; Araki H.; Kusaka M.; Harada M.; Cho N.; Suzuki N.; Furuya S.; Fujino M.; Suppression of a pituitary-ovarian axis by chronic oral administration of a novel nonpeptide gonadotropin-releasing hormone antagonist, TAK-013, in cynomolgus monkeys. J Clin Endocrinol Metab 2003,88(4),1697-1704","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00404-017-4328-6","volume":"295","author":"Alessandro P.","year":"2017","unstructured":"Alessandro P.; Luigi N.; Felice S.; Maria P.A.; Benedetto M.G.; Stefano A.; Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature. Arch Gynecol Obstet 2017,295(4),827-832","journal-title":"Arch Gynecol Obstet"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1021\/jm020180i","volume":"46","author":"Sasaki S.","year":"2003","unstructured":"Sasaki S.; Cho N.; Nara Y.; Harada M.; Endo S.; Suzuki N.; Furuya S.; Fujino M.; Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor. J Med Chem 2003,46(1),113-124","journal-title":"J Med Chem"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1016\/S0015-0282(02)03947-X","volume":"78","author":"Boyce M.","year":"2002","unstructured":"Boyce M.; Clark E.; Johnston A.; George M.; Davies J.; Hibberd M.; Effects of single and repeated oral doses of TAK-013, a new non-peptide gonadotropin-releasing hormone (GnRH) antagonist, in healthy post-menopausal women. Fertil Steril 2002,78,S281-S282","journal-title":"Fertil Steril"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1210\/jc.2015-2770","volume":"100","author":"MacLean D.B.","year":"2015","unstructured":"MacLean D.B.; Shi H.; Faessel H.M.; Saad F.; Medical castration using the investigational oral GnRH antagonist TAK-385 (relugolix): phase 1 study in healthy males. J Clin Endocrinol Metab 2015,100(12),4579-4587","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/173438","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/173438\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/173438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:59:25Z","timestamp":1695013165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/173438\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":160,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2020,11,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190712165444","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}